Tixagevimab-cilgavimab as an Early Treatment for COVID-19 in Kidney Transplant Recipients. Benotmane I, Olagne J, Gautier-Vargas G, Cognard N, et al. Transplantation 2023 Jun 21. doi: 10.1097/TP.0000000000004655.

Read + Share

Amedeo Smart

Independent Medical Education

Benotmane I, Olagne J, Gautier-Vargas G, Cognard N, et al. Tixagevimab-cilgavimab as an Early Treatment for COVID-19 in Kidney Transplant Recipients. Transplantation 2023 Jun 21. doi: 10.1097/TP.0000000000004655.
PMID: 37340538